Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 104,151 | 97,866 | 109,977 | -342,117 | 112,602 |
| Depreciation Amortization | 106,197 | 98,897 | 105,240 | 418,426 | 103,760 |
| Income taxes - deferred | -846 | 1,311 | -8,668 | -42,342 | 16,845 |
| Accounts receivable | -19,492 | -16,266 | 7,669 | -5,640 | 21,082 |
| Accounts payable and accrued liabilities | -7,080 | -3,257 | 2,208 | 71 | -11,349 |
| Other Working Capital | -25,357 | -25,860 | -27,784 | 7,556 | -43,575 |
| Other Operating Activity | 51,472 | 55,315 | 18,200 | 132,282 | 16,212 |
| Operating Cash Flow | $209,045 | $208,006 | $206,842 | $168,236 | $215,577 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39,154 | -47,534 | -49,143 | -42,860 | -79,853 |
| Net Acquisitions | -29,218 | -16,861 | N/A | N/A | -83,347 |
| Purchase Of Investment | -17,566 | -18,537 | -24,556 | -27,600 | -98,991 |
| Sale Of Investment | 11,584 | 25,156 | 31,607 | 72,464 | 50,484 |
| Other Investing Activity | 307 | 2,786 | 5,447 | 950 | 2,623 |
| Investing Cash Flow | $-74,047 | $-54,990 | $-36,645 | $2,954 | $-209,084 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 511,804 | 74,116 | 250,708 | 579,372 | 18,000 |
| Debt Repayment | -523,304 | -140,347 | -252,965 | -381,535 | -54,130 |
| Common Stock Issued | N/A | N/A | N/A | 4,492 | 819 |
| Common Stock Repurchased | -165,932 | -64,189 | -283,795 | -356,527 | -45,897 |
| Other Financing Activity | 93,195 | 19,299 | 14,266 | -13,697 | 231 |
| Financing Cash Flow | $-84,237 | $-111,121 | $-271,786 | $-167,895 | $-80,977 |
| Exchange Rate Effect | -2,613 | -1,009 | -7,107 | -10,293 | 3,736 |
| Beginning Cash Position | 109,685 | 68,905 | 179,160 | 182,574 | 243,592 |
| End Cash Position | 155,927 | 109,685 | 68,905 | 179,160 | 182,574 |
| Net Cash Flow | $46,242 | $40,780 | $-110,255 | $-3,414 | $-61,018 |
| Free Cash Flow | |||||
| Operating Cash Flow | 209,045 | 208,006 | 206,842 | 168,236 | 215,577 |
| Capital Expenditure | -39,154 | -47,534 | -49,143 | -42,860 | -79,853 |
| Free Cash Flow | 169,891 | 160,472 | 157,699 | 125,376 | 135,724 |